The biochemical mechanism of action (MOA) of pharmaceutical products is primarily determined by their active pharmaceutical ingredients (APIs), which can be engineered to exhibit an array of desirable effects on the body. However, new pharmaceuticals can cause unexpected and undesirable side-effects which outweigh their potential therapeutic benefits. Toxicology screening is routinely conducted on all raw materials used in drug manufacturing, including: process-aiding solvents and reagents; excipients; intermediates; APIs; and packaging media.
Jordi Labs specializes in tailor-made chemical testing for some of the most stringent industries worldwide. We can support you in your new drug development with expert toxicology screening in the research and development (R&D) phase. Identifying and characterizing the environmental and mammalian toxicology of proprietary pharmaceutical compounds at the outset is key. We can assist in target identification with a pre-clinical toxicological safety assessment; establishing comparative toxicity screens at the earliest stage in drug development to eliminate hazardous elements.
Our toxicology screening service can interweave your drug development program, from R&D to eventual end-product quality control. Our toxicologists can support you throughout the development and manufacturing process. Once a promising candidate drug has been identified, Jordi Labs can help you design, monitor, and interpret nonclinical toxicology, toxicokinetic, and pharmacokinetic studies. In addition, we can assist in the preparation of both regulatory and marketing submissions, including:
- Clinical trial applications (CTAs);
- Investigational new drug (IND);
- New drug application (NDA).
Toxicology Screening with Jordi Labs
Jordi Labs has the expertise necessary to perform toxicology screening and toxicity services for the pharmaceutical sector. If you would like more information about how we can partner together, please do not hesitate to contact us directly.
